Melanoma News and Research

Latest Melanoma News and Research

Scientists pioneer way to find more chromosomal aberrations in tumors

Scientists pioneer way to find more chromosomal aberrations in tumors

CDA attempts to clear confusion over vitamin D and sun exposure

CDA attempts to clear confusion over vitamin D and sun exposure

Surgeon uses radiotracers to detect the ganglion through which tumour attempts to spread

Surgeon uses radiotracers to detect the ganglion through which tumour attempts to spread

FDA accepts ZIOPHARM's IND for ZIN ATI-001 to treat melanoma

FDA accepts ZIOPHARM's IND for ZIN ATI-001 to treat melanoma

Scientists uncover new role for key cancer protein

Scientists uncover new role for key cancer protein

Neoprobe's Lymphoseek Phase 3 trial data presented at SNM annual meeting

Neoprobe's Lymphoseek Phase 3 trial data presented at SNM annual meeting

Eliminating ABCB5-expressing cells crucial for successful colorectal cancer treatment

Eliminating ABCB5-expressing cells crucial for successful colorectal cancer treatment

NYU Cancer Institute scientists present new research findings at ASCO 2011

NYU Cancer Institute scientists present new research findings at ASCO 2011

IsoRay completes Iotrex license agreement with Dr. Reddy's

IsoRay completes Iotrex license agreement with Dr. Reddy's

OncoSec announces additional evaluation of ElectroImmunotherapy Phase I trial on melanoma

OncoSec announces additional evaluation of ElectroImmunotherapy Phase I trial on melanoma

DxTerity acquires intellectual property rights to blood based genomic testing from SourceMDx

DxTerity acquires intellectual property rights to blood based genomic testing from SourceMDx

ABRAXANE and bevacizumab clinical studies on unresectable melanoma presented at ASCO 2011

ABRAXANE and bevacizumab clinical studies on unresectable melanoma presented at ASCO 2011

FDA lifts BioSante's GVAX Prostate Cancer Vaccine clinical hold

FDA lifts BioSante's GVAX Prostate Cancer Vaccine clinical hold

Independent investigators report Lymphoseek meets all endpoints in NEO3-09 Phase 3 study

Independent investigators report Lymphoseek meets all endpoints in NEO3-09 Phase 3 study

Initial positive results from ZIOPHARM's ZIN-CTI-001 Phase Ib study against advanced melanoma

Initial positive results from ZIOPHARM's ZIN-CTI-001 Phase Ib study against advanced melanoma

Celgene announces ABRAXANE plus gemcitabine, bevacizumab phase II trial data on breast cancer

Celgene announces ABRAXANE plus gemcitabine, bevacizumab phase II trial data on breast cancer

Study finds consistent link between Parkinson's disease and melanoma

Study finds consistent link between Parkinson's disease and melanoma

Synta presents ganetespib Phase 1, 2 trial results against solid tumors at ASCO 2011

Synta presents ganetespib Phase 1, 2 trial results against solid tumors at ASCO 2011

Scientists discover key molecule that targets tumour blood vessels

Scientists discover key molecule that targets tumour blood vessels

Senescent melanoma cells express an inflammatory secretome

Senescent melanoma cells express an inflammatory secretome

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.